Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant
Sponsor: University Hospital, Strasbourg, France
Summary
Lupus anticoagulant (LA) testing is performed using two screening tests: activated partial thromboplastin time (APTT) and diluted Russell's viper venom time. If one of the screening tests is positive, a confirmation test based on the same principle is performed. The HUS Hematology Laboratory uses an integrated APTT for LA testing, consisting of a screening reagent: Cephen LS, and a confirmation reagent: Cephen (Hyphen Biomed). The aim of this study is to determine whether another integrated activated partial thromboplastin time (APTT) test, Cryocheck HexLA, offers better performance than Cephen LS/Cephen, both in terms of sensitivity to lupus anticoagulant (LA) and susceptibility to interference from anticoagulant treatments.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-12-04
Completion Date
2026-02
Last Updated
2026-01-02
Healthy Volunteers
Not specified
Conditions
Locations (1)
Laboratoire d'Hématologie - CHU de Strasbourg - France
Strasbourg, France